Tysabri Lawsuits -
Research the Dangers of this MS Medication
Tysabri was supposed to help control exacerbations related to multiple sclerosis (MS). Marketing of Tysabri was suspended after patients in a clinical trial developed progressive multifocal leukoencephalopathy (PML), a rare neurologic disease. Whether you are looking to learn more about Tysabri, read breaking news & warnings, or get answers to frequently asked questions, you can use these pages to do your reseach.
Learn MorePML: Dangers Avonex Multiple Sclerosis Crohn's Disease |
News & WarningsBreaking News FDA Tysabri Alert Tysabri Health Advisory Treatment Approved |
Frequently Asked QuestionsLinks & Numbers |
Weitz & Luxenberg is no longer accepting Tysabri cases.
see also:
News & Warnings
Get help filing a Tysabri lawsuit if you were injured taking Tysabri (natalizumab)Tysabri lawsuit-if you were injured by Tysabri (natalizumab) - News
Learn More
Tysabri, PML and Avonex from sources such as the FDA - Learn MoreTysabri Resource Center-FDA information about Tysabri, PML and Avonex.
Research Center
Tysabri, PML and Avonex from sources such as the FDATysabri Resource Center-FDA information about Tysabri, PML and Avonex.

